Proxi Biotech

Copenhagen, Denmark

Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.

$526K raised

Feb 2025

Convertible Note

Biotechnology Health Care Medical Medical Device

Top Investors

BioInnovation Institute BioInnovation Institute Venture Lab

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Proxi Biotech

How much funding has Proxi Biotech raised?

Proxi Biotech has raised $526K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2025.

Who are Proxi Biotech's investors?

Proxi Biotech's investors include BioInnovation Institute, BioInnovation Institute Venture Lab.

Where is Proxi Biotech headquartered?

Proxi Biotech is headquartered in Copenhagen, Denmark.

What does Proxi Biotech do?

Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.

What stage is Proxi Biotech at?

Proxi Biotech is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2025.

MLA

"Proxi Biotech — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/proxi-biotech. Accessed July 2, 2026.

APA

VCBacked. (2025). Proxi Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/proxi-biotech

Wikipedia (cite web)

{{cite web |title=Proxi Biotech — Funding & Investors |url=https://www.vcbacked.co/company/proxi-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K